somber illustration of Atlanta Braves' Jurickson Profar in dugout with MLB 162-game PED suspension notice.
somber illustration of Atlanta Braves' Jurickson Profar in dugout with MLB 162-game PED suspension notice.
Image générée par IA

Jurickson Profar suspended 162 games for second PED violation

Image générée par IA

Major League Baseball suspended Atlanta Braves designated hitter Jurickson Profar for 162 games on Tuesday after he tested positive for exogenous testosterone and its metabolites. This marks his second violation of the league's Joint Drug Prevention and Treatment Program, following an 80-game ban in 2025. The suspension, effective Friday, March 6, bars him from the entire 2026 season, postseason, and the World Baseball Classic.

Jurickson Profar, who signed a three-year, $42 million contract with the Atlanta Braves in January 2025 after a standout 2024 season with the San Diego Padres, faced his second positive test for a performance-enhancing drug. In 2024, Profar earned All-Star and Silver Slugger honors, hitting .280 with a .380 on-base percentage, 24 home runs, and 85 RBI. However, his time with the Braves has been disrupted by PED issues.

On March 31, 2025, Profar tested positive for human chorionic gonadotropin, resulting in an 80-game suspension that made him ineligible for the postseason. He played four games before the ban and, upon return on July 2, batted .245/.353/.434 over 80 games, recording 14 home runs, 43 RBI, and 56 runs. The Braves missed the playoffs that year for the first time in eight seasons.

MLB announced the latest suspension Tuesday, stating Profar violated the Joint Drug Prevention and Treatment Program. As a second offense, the penalty is 162 games without pay, forfeiting his $15 million 2026 salary. He remains under contract for 2027 at $15 million but is ineligible for any postseason or international play, including the World Baseball Classic for the Netherlands, where he was scheduled to participate. Profar, 33, from Curaçao, was scratched from a Team Netherlands exhibition game Tuesday.

The Braves issued a statement: "We were incredibly disappointed to learn that Jurickson Profar tested positive for a performance-enhancing substance and is in violation of MLB's Drug Prevention and Treatment Program. Our players are consistently educated about the Program and the consequences if they are found to be in violation. The Atlanta Braves fully support the Program."

MLB increased the second-offense penalty to a full season in 2014; Profar is the seventh player to receive such a ban, the first since Milwaukee Brewers reliever J.C. Mejia in September 2023. The suspension leaves the Braves, NL East favorites entering spring training, searching for a designated hitter option amid other injuries, including elbow surgeries for pitchers Spencer Schwellenbach and Hurston Waldrep.

Ce que les gens disent

X discussions react with shock, frustration, and mockery to Jurickson Profar's 162-game suspension for a second PED violation involving exogenous testosterone. Braves fans lament the loss and call for roster moves, while media highlights the recurrence after his prior assurances and the substance's health impacts. Sentiments are overwhelmingly negative, with high-engagement posts from journalists confirming the news.

Articles connexes

Philadelphia Phillies outfielder Johan Rojas in uniform, looking serious on baseball field amid PED suspension news.
Image générée par IA

Phillies outfielder Johan Rojas faces 80-game PED suspension

Rapporté par l'IA Image générée par IA

Philadelphia Phillies outfielder Johan Rojas has tested positive for a performance-enhancing drug during the offseason and is appealing an 80-game suspension. The 25-year-old, who was set to play for the Dominican Republic in the World Baseball Classic, did not report to the tournament. Rojas remains eligible for spring training games while the appeal process continues.

Major League Baseball announced on Friday that free-agent outfielder Max Kepler has received an 80-game suspension after testing positive for the performance-enhancing substance Epitrenbolone. The 32-year-old, who played last season with the Philadelphia Phillies, accepted the penalty without contest. Kepler will be ineligible for the 2026 postseason if he signs with a team.

Rapporté par l'IA

Le professionnel allemand de baseball Max Kepler a été suspendu pour 80 matchs par la Major League Baseball. Le Berlinois de 32 ans a été contrôlé positif à l'Epitrenbolone, un stéroïde anabolisant. Kepler, actuellement sans contrat, n'a pas encore commenté l'accusation.

Les New York Mets ont conclu un contrat de deux ans avec l'intérieur Jorge Polanco, ancien des Seattle Mariners. La signature de Polanco met en lumière sa réduction remarquable du taux de strikeouts de 29,2 % en 2024 à 15,6 % en 2025, la plus forte baisse en une saison dans l'histoire de la MLB. Cette amélioration, due à la récupération de santé et à des ajustements de swing, le positionne comme un frappeur de puissance orienté contact pour les Mets.

Rapporté par l'IA

La Major League Baseball a annoncé de nouvelles limites sur les marchés de paris au niveau des lancers, plafonnant les mises à 200 dollars et les excluant des parlays, applicables immédiatement auprès des opérateurs couvrant plus de 98 % du marché américain. Ces mesures font suite à l'inculpation fédérale de dimanche des lanceurs des Cleveland Guardians Emmanuel Clase et Luis Ortiz pour avoir prétendument truqué des lancers au bénéfice de parieurs. La ligue vise à atténuer les risques d'intégrité posés par ces micro-paris sur des résultats comme les balles, strikes ou vitesse de lancer.

As the 2026 Baseball Hall of Fame vote results approach, CBS Sports writers Matt Snyder and Mike Axisa discuss their differing ballots. Their conversation highlights debates over performance-enhancing drugs, the Astros scandal and borderline candidates. Both emphasize the challenges of drawing lines on eligibility.

Rapporté par l'IA

Treize joueurs, principalement des lanceurs droitiers, ont été sélectionnés lors de la phase Ligue majeure du repêchage Rule 5 2025 tenu mercredi à Orlando, en Floride. Les Colorado Rockies ont ouvert en prenant le releveur RJ Petit des Detroit Tigers, tandis que les Chicago White Sox ont fait deux choix. Un seul joueur de position, le receveur Daniel Susac, a été choisi avant d’être échangé aux San Francisco Giants.

 

 

 

Ce site utilise des cookies

Nous utilisons des cookies pour l'analyse afin d'améliorer notre site. Lisez notre politique de confidentialité pour plus d'informations.
Refuser